How Has the Single-cell Analysis Market Size Evolved in Recent Years?
The single-cell analysis market has seen considerable growth due to a variety of factors.
• The market size of single-cell analysis has seen substantial growth lately. Projected growth is from $3.51 billion in 2024 to an anticipated $3.94 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%.
Factors such as elevating research in the field of genomics, augmented funding, and enhanced R&D in biopharmaceuticals have contributed to the growth in the historic period.
What are the Market Size and Expected Growth Rates for the Single-cell Analysis Market?
The single-cell analysis market is expected to maintain its strong growth trajectory in upcoming years.
• Rapid expansion is anticipated in the single-cell analysis market size over the coming years, with a projected value of $7.05 billion by 2029, reflecting a compound annual growth rate (CAGR) of 15.6%.
This predicted growth during the forecast period is due to a broader application range, increased utilization in clinical diagnostics, and advancements in data evaluation. Key trends expected during this period include collaborative efforts and partnerships, the integration of multi-omics, single-cell spatial analysis, the adoption of automation and high-throughput technologies, integration of AI and machine learning, and a wider application scope in neurology.
Which Drivers Are Accelerating Growth In The Single-cell Analysis Market?
The surge in prioritizing personalized medicine globally has been contributing to the expansion of the single-cell analysis market. Personalized medicine employs the genetic profile of a specific person to make informed decisions concerning disease prevention, diagnosis, and treatment. Single-cell analysis can facilitate the process of various disease treatments, by providing an in-depth understanding of each patient's needs, the disease's characteristics, and the tailored treatment. Consequently, there is a rise in patients choosing personalized medicines. For instance, the US-based non-profit organization, the Personalized Medicine Coalition, reported that in February 2024, the FDA sanctioned 16 new personalized therapies for patients suffering from rare diseases in 2023, a significant increase from six in 2022. Therefore, the growing emphasis on personalized medicine is bolstering the single-cell analysis market.
What Are The Core Segments Of The Global Single-cell Analysis Market?
The single-cell analysis market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Workflow: Single-Cell Isolation And Library Preparation, Downstream Analysis, Data Analysis
3) By Technique: Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction (PCR), Microscopy, Mass Spectrometry, Other Techniques
4) By Application: Cancer, Immunology, Neurology, Stem Cell, Non-invasive prenatal diagnosis, In-Vitro fertilization, Other Applications
5) By End User: Academic and Research Laboratories, Biotechnology And Pharmaceutical Companies, Hospital And Diagnostic Laboratories
Subsegments:
1) By Consumables: Reagents, Kits, Assay Plates And Containers, Microfluidic Chips
2) By Instruments: Flow Cytometers, Cell Sorters, Microscopes, Imaging Systems, Single-Cell Sequencers
Pre-Book The Single-cell Analysis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Single-cell Analysis Market Size?
Businesses in the single-cell analysis industry are concentrating on clinical diagnostic products like ddSEQTM Single-Cell 3' RNA-Seq Kit to aid in top-of-the-line single-cell RNA sequencing. This kit is intended for precise RNA sequencing, allowing for an extensive examination of gene expression within single cells. For instance, in June 2024, Bio-Rad, an American global lifescience and clinical diagnostics powerhouse, introduced the Single-Cell 3’ RNA-Seq Kit for individual cell gene expression. The kit, specifically meant for high-efficiency gene expression sequencing from solo cells, primarily captures the 3' termination of mRNA transcripts. Such a feature enables researchers to study and establish gene expression patterns in individual cells. Its broad use in cellular heterogeneity, developmental biology, and disease mechanisms studies offers valuable understanding into the intricate biological systems within the single-cell analysis market.
Who Are the Key Players in the Single-cell Analysis Market?
Major companies operating in the single-cell analysis market include:
• Becton Dickinson and Company
• Merck KGAA
• QIAGEN N. V.
• Thermo Fisher Scientific Inc.
• Illumina Inc.
• Standard BioTools Inc.
• 10X Genomics Inc.
• Bio-Rad Laboratories Inc.
• Novogene Corporation Limited
• Agilent Technologies Inc.
• Sartorius AG
• Luminex Corporation
• Fluxion Biosciences Inc.
• Oxford Nanopore Technologies Ltd.
• 1CellBio Inc.
• 3D Biomatrix Inc.
• ACEA Biosciences Inc.
• Akoya Biosciences Inc.
• Berkeley Lights Inc.
• Bio-Techne Corporation
• Celsee Inc.
• Cellular Research Inc.
• Cytena GmbH
• Dolomite Bio Limited
• Drop-seq Technologies Inc.
• Epic Sciences Inc.
• Ginkgo Bioworks Inc.
• IsoPlexis Corporation
• Menarini Silicon Biosystems S. p. A.
• Mission Bio Inc.
• NanoCellect Biomedical Inc.
• NemaMetrix Inc.
• OnRamp Bioinformatics Inc.
• Partek Incorporated
• RareCyte Inc.
• Scienion AG
• SeqWell Inc.
• Sphere Fluidics Limited
• Takara Bio USA Holdings Inc.
What are the Regional Insights into the Single-cell Analysis Market?
North America was the largest region in the single-cell analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
